Xanomeline oxalate is primarily used in the field of neuroscience and pharmacology due to its role as a muscarinic acetylcholine receptor agonist. It has been investigated for its potential in treating cognitive disorders, particularly Alzheimer's disease, by enhancing cholinergic transmission in the brain. This mechanism helps improve memory and cognitive function in patients. Additionally, it has been studied for its potential antipsychotic effects, offering promise in managing symptoms of schizophrenia by modulating neurotransmitter activity. Research also explores its application in addressing other neurological conditions, such as Parkinson's disease, due to its ability to influence dopaminergic pathways. Its therapeutic potential continues to be a focus in developing treatments for central nervous system disorders.